Stock Market News 15 December 2025

Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

December 15, 2025 — Applied Digital Corporation (NASDAQ: APLD) has become one of the market’s most talked-about “picks-and-shovels” names in the AI boom: not a chipmaker, not a model builder, but a company racing to deliver the hard part of modern AI at scale—power-dense data centers. That positioning helped propel APLD sharply higher over 2025, but it also made the stock a magnet for volatility. Coming into mid-December, shares were hovering around the high-$20s, after a sharp one-day drop that reminded investors this is still a capital-intensive buildout story with real financing, execution, and tenant risks. StockAnalysis Below is a

15 December 2025

NASDAQ:APLD·Stock Market

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health, Inc. (NYSE: OSCR) is back in the spotlight on December 15, 2025, as investors track a rare triple intersection of (1) U.S. health-policy headlines, (2) new analyst coverage and price-target resets, and (3) the most time-sensitive part of Affordable Care Act (ACA) open enrollment. As of the latest available market data, OSCR last traded around $16.63, with a market cap near $4.24 billion and a 52-week range of roughly $11.20 to $22.40. This is not a “set it and forget it” stock. Oscar is tightly linked to the economics of ACA marketplaces—and this week, the ACA story is

15 December 2025

NYSE:OSCR·Stock Market

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi stock is under pressure on December 15, 2025, after the French drugmaker disclosed two setbacks tied to its experimental multiple sclerosis (MS) medicine tolebrutinib—a regulatory delay in the U.S. for one progressive MS form and a failed Phase 3 endpoint in another. The update pushed Sanofi shares down about 4% in Paris trading, as investors recalibrated expectations for one of the company’s closely watched late-stage pipeline assets. Reuters+1 For U.S. investors watching the ADR, Sanofi (NASDAQ: SNY) traded around $48.68 at the latest timestamp available from market data in this session (10:15 UTC), modestly lower on the day. Below

15 December 2025

EPA:SAN.PA·NASDAQ:SNY·Pharmaceuticals·Stock Market

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

December 15, 2025 — Alibaba Group Holding Limited (NYSE: BABA; HKEX: 9988) is heading into year-end with investors focused on one big question: can its aggressive AI-and-cloud push translate into durable profits before the bills for chips, data centers, and instant-delivery subsidies come due? As of Monday, Dec. 15, 2025, Alibaba’s U.S.-listed ADR was trading around $155.68. Below is a deep, current read of the main catalysts and risks shaping Alibaba stock right now—based on the most recent reporting and analyst updates available as of 15.12.2025. Alibaba stock price today: where BABA stands on Dec. 15, 2025 Alibaba’s ADR is

15 December 2025

Financial Forecasts·HKG:9988·NYSE:BABA·Stock Market

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

December 15, 2025 — New Fortress Energy Inc. (NASDAQ: NFE) is back in the market spotlight as investors weigh a high-stakes mix of near-term debt pressure and fresh operating/contract progress. The stock traded around $1.26 in early data on Monday, down about 2.3% from the prior close. That price action isn’t happening in a vacuum. December 15 is also a date that shows up repeatedly in the company’s recent disclosures: it’s the end of a forbearance window tied to a missed interest payment—one of the central reasons NFE has been trading like a “headline-sensitive” distressed equity rather than a typical

15 December 2025

NASDAQ:NFE·Stock Market

GE Aerospace Stock (NYSE: GE) News Today: Citi’s $386 Target, FAA LEAP Inspections, Navy Orders, and What to Watch Into 2026

GE Aerospace stock is back in the market’s spotlight heading into mid-December, trading around $299.81 and up roughly 4% versus the prior close in the latest available quote. That move isn’t happening in a vacuum. Over the past several days, GE has landed fresh bullish Wall Street coverage, surfaced in defense-related headlines, and found itself indirectly tied to a regulatory development affecting the CFM LEAP engine family—one of the most important programs in modern commercial aviation. Below is what’s driving GE Aerospace stock right now, how analysts are framing upside (and limits), and what investors will be watching as GE

15 December 2025

Aerospace Industry·Financial Forecasts·NYSE:GE·Stock Market

Micron Technology (MU) Stock News and Forecast — Dec. 15, 2025: Earnings Preview, AI Memory Crunch, and Wall Street Price Targets

Micron Technology, Inc. (NASDAQ: MU) heads into mid-December with one big, market-moving catalyst: its fiscal first-quarter 2026 earnings report and conference call on Wednesday, Dec. 17, 2025. Micron Technology+1 After an explosive 2025 run—Micron shares have gained more than 200% year-to-date in some tallies—investors are now trying to answer a more delicate question: Is MU still in the early innings of an “AI memory supercycle,” or are expectations so high that even good results could trigger a sell-the-news reaction? Investopedia As of the latest available quote in this briefing, MU is around $241.14, which implies a roughly 6.7% drop versus

15 December 2025

Earnings Reports·NASDAQ:MU·Stock Market

Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. (NASDAQ: IXHL) is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session. The renewed attention isn’t coming out of nowhere. Over the past several weeks, Incannex has stacked up a series of developments that matter to speculative biotech investors: a U.S. FDA Fast Track designation for its lead obstructive sleep apnea (OSA) program, a Nasdaq minimum bid-price compliance deadline now pushed into 2026, and fresh research commentary from at least one boutique coverage firm—along with a mixed

15 December 2025

NASDAQ:IXHL·Stock Market

ImmunityBio (IBRX) Stock in Focus on Dec. 15, 2025: EMA’s ANKTIVA Nod, Analyst Targets, and What Comes Next

December 15, 2025 — ImmunityBio, Inc. (NASDAQ: IBRX) is back on investors’ radar today as fresh coverage and new analysis dig into a major European regulatory milestone for its lead therapy ANKTIVA (nogapendekin alfa inbakicept). The market’s obsession is simple: does this become the catalyst that turns ImmunityBio into a real commercial oncology story—or just the latest biotech pop before the harder work of reimbursement, uptake, and cash management begins? Below is a complete, publication-ready roundup of the news, forecasts, and market analysis circulating on December 15, 2025, plus the key fundamentals investors are weighing right now. Why ImmunityBio stock

15 December 2025

Financial Forecasts·NASDAQ:IBRX·Stock Market

China AI Stocks Today (Dec. 15, 2025): A‑Shares and Hong Kong Tech Slide as CPO & AI Chips Cool—What Analysts Forecast Next

Shanghai/Hong Kong — Dec. 15, 2025 — China’s AI-linked stocks started the week on the back foot, with A‑share “computing power” (算力) hardware names and Hong Kong tech leaders retreating amid a risk-off mood across Asia. Traders pointed to a combination of global “AI capex trade” jitters, softer China macro signals, and year‑end liquidity that amplified moves—especially in the high‑beta AI supply chain. CLS+3Reuters+3Saxo+3 Still, Monday’s tape also showed something important for anyone following China AI stocks: the pullback was selective, with pockets of robotics and AI applications holding up, and several research desks arguing that the 2026 AI buildout

15 December 2025

Stock Market

Tokyo AI Stocks Slide as SoftBank, Advantest Drag Nikkei on Dec. 15, 2025 — BOJ Rate Hike in Focus

Tokyo’s AI-linked stocks took a clear hit on Monday, December 15, 2025, as a pullback in global tech sentiment spilled into Japan’s market and triggered a rotation away from some of the year’s biggest “AI trade” winners. The headline move was in the Nikkei 225, which is heavily influenced by large, high-priced tech names. The index fell 1.31% to 50,168.11, even as the broader Topix gained 0.22% to 3,431.47—a split that underscored how concentrated the pressure was in AI- and semiconductor-related shares rather than across the entire market. Nasdaq Behind the day’s swings: renewed valuation concerns around global AI spending,

15 December 2025

Artificial Intelligence·Japan Economy·Stock Market·TSX:6857·TSX:8035·TSX:9984

Oklo Inc Stock (OKLO) on Dec. 15, 2025: Latest News, $1.5B ATM Offering, Analyst Forecasts, and What Investors Are Watching

December 15, 2025 — Oklo Inc. (NYSE: OKLO) is starting the week with investors trying to separate two very different stories that have become tangled together: the long, regulated march toward advanced nuclear deployment, and the short, adrenaline-fueled “AI infrastructure” trade that just took a hit. The immediate backdrop is brutal volatility. OKLO closed at $87.42 on Friday, Dec. 12, down about 15% on the day after trading as high as roughly $103 earlier in the session. StockAnalysis+1 That selloff came as markets rotated away from AI-linked names on renewed “AI bubble” jitters—Oklo was explicitly called out among the AI-infrastructure

15 December 2025

NYSE:OKLO·Stock Market

Previous 1 … 1,267 1,268 1,269 1,270 1,271 … 1,947 Next

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026

Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026

The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.

Tesla stock price rises to $411 as Musk solar hiring push and China AI plan set up week ahead

7 February 2026

Tesla shares closed up 3.5% at $411.11 on Friday after news of a U.S. solar hiring push and an AI training center in China. The company targets 100 GW of U.S. solar manufacturing by 2028, far above current national output. Investors remain focused on Tesla’s autonomy and energy projects. Upcoming U.S. jobs and inflation data may affect market sentiment next week.

Palantir stock price rebounds to $135.90 on Cognizant AI deal — what to watch next week

7 February 2026

Palantir shares closed Friday at $135.90, up 4.5% after Cognizant’s TriZetto unit announced plans to deploy Palantir Foundry and AIP in healthcare and business-process operations. The Dow closed above 50,000 for the first time. U.S. jobs and inflation data due next week may shift rate expectations for high-growth software stocks.

Stock Market News 15 December 2025

Stock Market Today